CARDIAC INVOLVEMENT IN CHRONIC INTESTINAL DISEASES

View at publisher Summarise with VIRAT
Authors: Sedef Öksüz
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Chronic intestinal disorders such as Inflammatory Bowel Disease (IBD) and Celiac Disease are well recognized not only for their gastrointestinal manifestations but also for their wide spectrum of extraintestinal systemic involvement. Among these, cardiovascular complications occupy a prominent position due to their association with increased morbidity and mortality. Both conditions share several pathophysiological mechanisms, including systemic inflammation, autoimmunity, endothelial dysfunction, hypercoagulability, and nutritional deficiencies secondary to malabsorption.IBD, encompassing Crohn’s disease and ulcerative colitis, represents a chronic immune-mediated inflammatory disorder. Cardiovascular manifestations reported in IBD include myocarditis, pericarditis, thromboembolic events, premature atherosclerosis, heart failure, arrhythmias, and valvular involvement. Among these, pericarditis is the most frequently described cardiac extraintestinal manifestation, followed by myocarditis. Chronic inflammation may lead to collagen deposition within the myocardium, resulting in structural remodeling and impaired contractile function. Additionally, chronic malabsorption can cause deficiencies in essential nutrients such as selenium and carnitine, which may lead to reversible or dilated cardiomyopathy, respectively.Venous thromboembolism (VTE) represents a major source of morbidity and mortality in IBD. Low-molecular-weight heparin (LMWH) prophylaxis is therefore recommended during hospitalization to reduce VTE risk. Furthermore, IBD has been linked to an increased risk of acute myocardial infarction, particularly within the first year after diagnosis and in patients with colonic involvement. Among therapeutic agents, 5-aminosalicylic acid (5-ASA) compounds are the most common cause of drug-induced pericarditis and myocarditis, including in pediatric patients.Celiac disease is an autoimmune enteropathy triggered by exposure to gluten in genetically susceptible individuals. Chronic immune activation and cross-reactivity of IgA antibodies with myocardial tissue contribute to cardiac involvement. Celiac cardiomyopathy is a serious condition that can affect both adults and children and is often observed in patients with idiopathic dilated cardiomyopathy. For early detection of subclinical myocardial dysfunction in pediatric patients, two-dimensional speckle-tracking echocardiography (2D-STE) and tissue Doppler imaging (TDI) are valuable diagnostic tools.Improving cardiovascular outcomes in these patients requires a comprehensive and multidisciplinary approach. Effective inflammation control in IBD and strict adherence to a gluten-free diet in celiac disease remain the cornerstones of management. Close collaboration between gastroenterologists and cardiologists, alongside careful monitoring of disease activity, is essential to minimize cardiovascular risk and improve long-term prognosis.Keywords: Inflammatory bowel disease; Celiac disease; Myocarditis; Cardiomyopathy, Dilated; Atherosclerosis; Pericarditis

Fields of Study & Subjects

Inflammatory Bowel Disease Celiac Disease Research and Management Ocular Diseases and Behçet’s Syndrome

Publication details

Journal / source
Turkiye Klinikleri eBooks
Pages
199–210
Publication date
1 January 2026
Language
EN
Document type
Book chapter